US Patent Issued to SHENZHEN PORSHEALTH BIOENGINEERING on Oct. 20 for "Bifidobacterium animalis subsp. lactis ATM-209 inhibiting helicobacter pylori and application thereof" (Chinese Inventors)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,766,174, issued on Oct. 20, was assigned to SHENZHEN PORSHEALTH BIOENGINEERING Co. LTD. (Shenzhen, China).

"Bifidobacterium animalis subsp. lactis ATM-209 inhibiting helicobacter pylori and application thereof" was invented by Guoxun Xiao (Shenzhen, China), Yanyi Zheng (Shenzhen, China), Silu Zhang (Shenzhen, China), Yuebiao Feng (Shenzhen, China) and Xin Teng (Shenzhen, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to the technical field of microorganisms, in particular to a Bifidobacterium animalis subsp. lactis ATM-209 (GOLDGUT-BB18) inhibiting Helicobacter Pylori and an application thereof. The Bifidobacterium an...